PRECIGEN, INC. Shares Outstanding (Cover Page)
PRECIGEN, INC. (PGEN) had Shares Outstanding (Cover Page) of 358.04 million shares as of 2026-07-31, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-04
- 2026-07-31: Entity Common Stock, Shares Outstanding 358.04M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 356.51M shares.
- 2026-02-15: Entity Common Stock, Shares Outstanding 353.93M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 353.82M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 358.04M shares 10-Q · filed 2026-08-04 |
| 2026-04-30 | 356.51M shares 10-Q · filed 2026-05-13 |
| 2026-02-15 | 353.93M shares 10-K · filed 2026-03-25 |
| 2025-10-31 | 353.82M shares 10-Q · filed 2025-11-13 |
| 2025-07-31 | 297.97M shares 10-Q · filed 2025-08-12 |
| 2025-04-30 | 295.18M shares 10-Q · filed 2025-05-14 |
| 2025-04-25 | 295.17M shares 10-K/A · filed 2025-04-28 |
| 2025-02-15 | 294.04M shares 10-K · filed 2025-03-19 |
| 2024-10-31 | 292.87M shares 10-Q · filed 2024-11-14 |
| 2024-07-31 | 252.76M shares 10-Q · filed 2024-08-14 |
| 2024-04-30 | 252.42M shares 10-Q · filed 2024-05-14 |
| 2024-04-26 | 252.42M shares 10-K/A · filed 2024-04-29 |
| 2024-02-15 | 248.92M shares 10-K · filed 2024-03-19 |
| 2023-10-31 | 248.92M shares 10-Q · filed 2023-11-09 |
| 2023-07-31 | 255.48M shares 10-Q · filed 2023-08-09 |
| 2023-04-30 | 255.48M shares 10-Q · filed 2023-05-10 |
| 2023-02-15 | 252.19M shares 10-K · filed 2023-03-06 |
| 2022-10-31 | 208.15M shares 10-Q · filed 2022-11-09 |
| 2022-07-31 | 208.15M shares 10-Q · filed 2022-08-08 |
| 2022-04-30 | 207.69M shares 10-Q · filed 2022-05-09 |
| 2022-02-15 | 206.93M shares 10-K · filed 2022-03-01 |
| 2021-10-31 | 206.74M shares 10-Q · filed 2021-11-08 |
| 2021-07-31 | 206.64M shares 10-Q · filed 2021-08-09 |
| 2021-04-30 | 206.41M shares 10-Q · filed 2021-05-10 |
| 2021-02-15 | 205.66M shares 10-K · filed 2021-03-01 |
| 2020-10-31 | 185.46M shares 10-Q · filed 2020-11-09 |
| 2020-07-31 | 172.31M shares 10-Q · filed 2020-08-10 |
| 2020-04-30 | 171.01M shares 10-Q · filed 2020-05-11 |
| 2020-02-15 | 169.67M shares 10-K · filed 2020-03-02 |
| 2019-10-31 | 162.68M shares 10-Q · filed 2019-11-12 |
| 2019-07-31 | 162.07M shares 10-Q · filed 2019-08-09 |
| 2019-04-30 | 160.76M shares 10-Q · filed 2019-05-09 |
| 2019-02-15 | 160.41M shares 10-K · filed 2019-03-01 |
| 2018-10-31 | 137.22M shares 10-Q · filed 2018-11-08 |
| 2018-07-31 | 136.99M shares 10-Q · filed 2018-08-13 |
| 2018-04-30 | 129.29M shares 10-Q/A · filed 2018-08-13 |
| 2018-02-15 | 129.07M shares 10-K · filed 2018-03-01 |
| 2017-10-31 | 120.72M shares 10-Q · filed 2017-11-09 |
| 2017-07-31 | 120.52M shares 10-Q · filed 2017-08-09 |
| 2017-04-30 | 119.61M shares 10-Q · filed 2017-05-10 |
| 2017-02-15 | 118.73M shares 10-K · filed 2017-03-01 |
| 2016-10-31 | 118.58M shares 10-Q · filed 2016-11-09 |
| 2016-07-31 | 118.33M shares 10-Q · filed 2016-08-09 |
| 2016-04-30 | 118.16M shares 10-Q · filed 2016-05-10 |
| 2016-02-15 | 116.78M shares 10-K · filed 2016-02-29 |
| 2015-10-31 | 116.40M shares 10-Q · filed 2015-11-09 |
| 2015-07-31 | 109.76M shares 10-Q · filed 2015-08-10 |
| 2015-04-30 | 109.25M shares 10-Q · filed 2015-05-11 |
| 2015-02-15 | 104.98M shares 10-K · filed 2015-03-02 |
| 2014-11-07 | 100.52M shares 10-Q · filed 2014-11-13 |
| 2014-08-08 | 100.48M shares 10-Q · filed 2014-08-14 |
| 2014-05-01 | 98.83M shares 10-Q · filed 2014-05-09 |
| 2014-03-20 | 97.79M shares 10-K · filed 2014-03-31 |
| 2013-11-01 | 96.99M shares 10-Q · filed 2013-11-07 |
| 2013-09-16 | 96.99M shares 10-Q/A · filed 2013-10-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |